• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10622
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Arteriosclerosis/ Atherosclerosis (4437)
Event Date 03/18/2022
Event Type  Injury  
Event Description
Synergy (b)(6) registry it was reported that arteriosclerotic heart disease occurred.In (b)(6) 2020, the subject was referred for cardiac catheterization and the index procedure was performed on the same day.The target lesion 1 was located in the proximal right coronary artery (rca) with 85% stenosis and was 32 mm long, with a reference vessel diameter of 3.5 mm.The lesion was treated with pre-dilatation and placement of a 3.50 mm x 32 mm synergy stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Three days post procedure, the subject was discharged on aspirin and ticagrelor.In (b)(6) 2022, the subject was diagnosed with arteriosclerotic heart disease and was hospitalized on the same day for further evaluation and treatment.Medication was given to treat the event.Five days later, the event was considered to be recovered/resolved and on the same day the subject was discharged on aspirin and ticagrelor.
 
Event Description
Synergy china registry.It was reported that arteriosclerotic heart disease occurred.In (b)(6) 2020, the subject was referred for cardiac catheterization and the index procedure was performed on the same day.The target lesion 1 was located in the proximal right coronary artery (rca) with 85% stenosis and was 32 mm long, with a reference vessel diameter of 3.5 mm.The lesion was treated with pre-dilatation and placement of a 3.50 mm x 32 mm synergy stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Three days post procedure, the subject was discharged on aspirin and ticagrelor.In (b)(6) 2022, the subject was diagnosed with arteriosclerotic heart disease and was hospitalized on the same day for further evaluation and treatment.Medication was given to treat the event.Five days later, the event was considered to be recovered/resolved and on the same day the subject was discharged on aspirin and ticagrelor.It was further reported that the patient was hospitalized with chest tightness.There was no re-stenosis of other blood vessels in the patient, and there was no more evidence to prove that the patient physical discomfort was unrelated to the device.Therefore, the correlation between the patient physical discomfort and the device could not be ruled out.
 
Manufacturer Narrative
B5-describe event or problem has been updated.H6.Patient code-added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key14283763
MDR Text Key290761947
Report Number2134265-2022-04778
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/27/2020
Device Model Number10622
Device Catalogue Number10622
Device Lot Number0024062929
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/21/2022
Initial Date FDA Received05/04/2022
Supplement Dates Manufacturer Received10/21/2022
Supplement Dates FDA Received11/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/03/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age58 YR
Patient SexMale
-
-